GH1 and melanoma: We have previously shown that among nine types of human cancers in the National Cancer Institute (NCI-60) panel of 60 cell lines, all of the melanoma cell lines exhibit the highest levels of GHR, and the treatment of these cells with recombinant hGH resulted in increased melanoma proliferation and activation of oncogenic signaling intermediates [56].